Crizotinib, Free Base [CAS# 877399-52-5]

C-7900

Crizotinib, Free Base [CAS# 877399-52-5]

303.5 €

202222

Crizotinib

435 €

1934-25

Crizotinib

1228.2 €

T6357-5mg

(S)-crizotinib

(S)-crizotinib

Ask for quotation

HY-50878S

Crizotinib-d5

Crizotinib-d5 is the deuterium labeled Crizotinib. Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib is also a ROS1 inhibitor. Crizotinib has effective tumor growth inhibition[1][2][3].

662.41 €

HY-50878B

Crizotinib (acetate)

Crizotinib (PF-02341066) acetate is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib acetate inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib acetate is also a ROS1 inhibitor. Crizotinib acetate has effective tumor growth inhibition[1][2][3].

Ask for quotation